1 study found for:    NCT00942877
Show Display Options
Rank Status Study
1 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171

Indicates status has not been verified in more than two years